MeMed raised €3.3M in a funding round in Jan 2018. The company is based in Tirat Carmel, Israel. Investors in the round: DoD’s Congressionally Directed Medical Research Programs (CDMRP). Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
